Sean David to Pharmacogenetics
This is a "connection" page, showing publications Sean David has written about Pharmacogenetics.
Connection Strength
1.628
-
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
Score: 0.725
-
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res. 2011 Mar; 13(3):157-67.
Score: 0.279
-
Pharmacogenetics. Prim Care. 2004 Sep; 31(3):543-59, ix.
Score: 0.179
-
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics. 2018 07 01; 19(10):861-871.
Score: 0.117
-
Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014 Mar 12; 311(10):1035-45.
Score: 0.087
-
Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb; 15(2):518-26.
Score: 0.078
-
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85.
Score: 0.058
-
Are family physicians willing to use pharmacogenetics for smoking cessation therapy? Fam Med. 2003 Feb; 35(2):83.
Score: 0.040
-
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. Nicotine Tob Res. 2018 03 06; 20(4):403-413.
Score: 0.029
-
Biomarkers for smoking cessation. Clin Pharmacol Ther. 2013 Jun; 93(6):526-38.
Score: 0.020
-
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 2010 Mar; 11(3):357-67.
Score: 0.016